Sickle cell pain: a critical reappraisal.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Blood

• Publication date

  1998-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/blood-2012-04-383430PMID 22923496
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of Morphine on Pericyte-Endothelial Interaction: Implications for Antiangiogenic Therapy

  2012cited by this paper
• Thirty‐day readmission rates following hospitalization for pediatric sickle cell crisis at freestanding children's hospitals: Risk factors and hospital variation

  2012cited by this paper
• Bilateral Mental Nerve Neuropathy in an Adolescent During Sickle Cell Crises

  2012cited by this paper
• Transient receptor potential vanilloid type 1 and pain development.

  2012cited by this paper
• Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness

  2012cited by this paper
• Beyond the Definitions of the Phenotypic Complications of Sickle Cell Disease: An Update on Management

  2012cited by this paper
• Pain management.

  2012cited by this paper
• More definitions in sickle cell disease: Steady state v base line data

  2012cited by this paper
• The Impact of Parenteral Narcotic Choice in the Development of Acute Chest Syndrome in Sickle Cell Disease

  2011cited by this paper
• Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease.

  2011cited by this paper
• Blockade of PDGFR-β Activation Eliminates Morphine Analgesic Tolerance

  2011cited by this paper
• Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial.

  2011cited by this paper
• 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in c

  2011cited by this paper
• Sickle Cell Pain

  2011cited by this paper
• Potential psychosocial risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.

  2011cited by this paper
• Morphine Induces Expression of Platelet-Derived Growth Factor in Human Brain Microvascular Endothelial Cells: Implication for Vascular Permeability

  2011cited by this paper
• Potential autonomic risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.

  2011cited by this paper
• Orofacial manifestations in patients with sickle cell anemia.

  2011cited by this paper
• Hydroxyurea and acute painful crises in sickle cell anemia: effects on hospital length of stay and opioid utilization during hospitalization, outpatient acute care contacts, and at home.

  2010cited by this paper
• Early Detection of Response to Hydroxyurea Therapy in Patients with Sickle Cell Anemia

  2010cited by this paper
• Plasminogen activators in ischemic stroke: introduction.

  2010cited by this paper
• Beneficial effects of nitric oxide breathing in adult patients with sickle cell crisis

  2010cited by this paper
• Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids.

  2010cited by this paper
• Sickle cell disease in the United States: Looking back and forward at 100 years of progress in management and survival

  2010cited by this paper
• The dark side of the discovery of sickle cell disease in the United States in 1910.

  2010cited by this paper
• The impact of hydroxyurea on career and employment of patients with sickle cell anemia.

  2010cited by this paper
• Acute care utilization and rehospitalizations for sickle cell disease.

  2010cited by this paper
• Disorders of Hemoglobin: Sickle Cell Pain: Biology, Etiology, and Treatment

  2009cited by this paper
• Disorders of hemoglobin: Genetics, pathophysiology, and clinical management, second edition

  2009cited by this paper
• Allogeneic hematopoietic stem-cell transplantation for sickle cell disease.

  2009cited by this paper
• Pain site frequency and location in sickle cell disease: The PiSCES project

  2009influential reference
• Hydroxyurea in children with sickle cell disease: Practice patterns and barriers to utilization

  2009influential reference
• Risk factors for hospital readmission within 30 days: A new quality measure for children with sickle cell disease

  2009cited by this paper
• Pain in Sickle Cell Disease: A Multidimensional Construct

  2007cited by this paper
• Central sensitization: uncovering the relation between pain and plasticity.

  2007cited by this paper
• Neurokinin-1 Receptor Enhances TRPV1 Activity in Primary Sensory Neurons via PKCε: A Novel Pathway for Heat Hyperalgesia

  2007cited by this paper
• COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia

  2007cited by this paper
• Guidelines for the Early Management of Adults With Ischemic Stroke

  2007cited by this paper
• Renaissance of sickle cell disease research in the genome era

  2007cited by this paper
• ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie

  2007cited by this paper
• Acute post operative pain

  2006cited by this paper
• Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia

  2006cited by this paper
• Wall and Melzack's textbook of pain

  2006cited by this paper
• Morphine stimulates vascular endothelial growth factor-like signaling in mouse retinal endothelial cells.

  2006cited by this paper
• Are there phases to the vaso-occlusive painful episode in sickle cell disease?

  2005cited by this paper
• Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome

  2005cited by this paper
• Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance

  2005cited by this paper
• Pain management of sickle cell disease.

  2005cited by this paper
• Morphine Induces Kidney Injury in Transgenic Sickle Cell Mice.

  2005cited by this paper
• Changes in intensity, location, and quality of vaso‐occlusive pain in children with sickle cell disease

  2003cited by this paper
• Causes of death in sickle cell disease: an autopsy study

  2003cited by this paper
• Systemic Exposure to Morphine and the Risk of Acute Chest Syndrome in Sickle Cell Disease

  2003cited by this paper
• Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases.

  2003cited by this paper
• Bonica's Management of Pain.

  2002cited by this paper
• Characteristics of pain managed at home in children and adolescents with sickle cell disease by using diary self-reports.

  2002cited by this paper
• Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth.

  2002cited by this paper
• Home Management of Pain in Sickle Cell Disease: A Daily Diary Study in Children and Adolescents

  2002cited by this paper
• Bonica's Management of Pain

  2001cited by this paper
• Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group.

  2000cited by this paper
• Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism.

  2000cited by this paper
• Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease

  2000cited by this paper
• Sequential nitric oxide measurements during the emergency department treatment of acute vasoocclusive sickle cell crisis

  2000cited by this paper
• Sickle cell anemia as an inflammatory disease.

  2000cited by this paper
• Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises.

  2000cited by this paper
• A chronology of pain and comfort in children with sickle cell disease.

  1999cited by this paper
• Sickle cell disease: clinical management.

  1998cited by this paper
• 7 Sickle cell disease: clinical management

  1998cited by this paper
• Pathogenesis and treatment of sickle cell disease.

  1997cited by this paper
• Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease.

  1997cited by this paper
• Ulnar nerve entrapment at the elbow: correlation of magnetic resonance imaging, clinical, electrodiagnostic, and intraoperative findings.

  1996cited by this paper
• Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology.

  1996cited by this paper
• Hydroxyurea and Sickle Cell Anemia Clinical Utility of a Myelosuppressive “Switching” Agent

  1996cited by this paper
• Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

  1995cited by this paper
• The sickle cell painful crisis in adults: phases and objective signs.

  1995cited by this paper
• Morphine stimulates superoxide formation by glomerular mesangial cells

  1994cited by this paper
• The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

  1994cited by this paper
• Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes.

  1994cited by this paper
• The spectrum of epilepsy in sickle cell anemia.

  1994cited by this paper
• Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia.

  1994cited by this paper
• The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease.

  1994cited by this paper
• Pain measurement in hospitalized adults with sickle cell painful episodes.

  1993cited by this paper
• Death from a morphine infusion during a sickle cell crisis.

  1993cited by this paper
• Rheological changes in the prodromal and established phases of sickle cell vaso‐occlusive crisis

  1992cited by this paper
• Treating Sickle Cell Pain like Cancer Pain

  1992cited by this paper
• Treating Sickle Cell Pain like Cancer Pain

  1992cited by this paper
• Acute splenic sequestration crisis in sickle cell disease: early detection and treatment.

  1992cited by this paper
• Red blood cell changes during the evolution of the sickle cell painful crisis.

  1992cited by this paper
• Diagnosis and management of common bile duct stones in patients with sickle hemoglobinopathies.

  1992cited by this paper
• Treating sickle cell pain like cancer pain.

  1992cited by this paper
• Vascular occlusion in sickle cell disease: current concepts and unanswered questions.

  1991cited by this paper
• The Management of Pain, 2nd ed.

  1991cited by this paper
• Mononeuropathy in sickle cell anemia: Anatomical and pathophysiological basis for its rarity

  1991cited by this paper
• Generation of acute pain: central mechanisms.

  1991cited by this paper
• Long-term management of splenic sequestration in children with sickle cell disease.

  1990cited by this paper
• Modified method of exchange transfusion in sickle cell disease

  1990cited by this paper
• Sickle cell anemia and major organ failure.

  1990cited by this paper
• The variable expression of sickle cell disease is genetically determined.

  1990cited by this paper
• John J. Bonica distinguished lecture. Acute pain and the injury response: immediate and prolonged effects.

  1989cited by this paper
• Acute Pain and the Injury Response: Immediate and Prolonged Effects

  1989cited by this paper
• Leg ulcers in patients with sickle cell disease.

  1989cited by this paper

• Factors Associated with Healthcare Utilization in Children with Sickle Cell Disease in Saudi Arabia

  2026cites this paper
• Evaluation of the Neuropathic Component of Pain in Sickle Cell Disease.

  2026cites this paper
• Using a Shared Infusion Clinic for Outpatient Management of Sickle Cell Vaso‐Occlusive Crisis as a Strategy of Decreasing Emergency Department Visits

  2026cites this paper
• You Only Work with What You Know: Healthcare providers' experiences using non-pharmacological interventions in managing sickle cell crisis pain in adolescents.

  2025cites this paper
• Deciphering Pain Experience in Adult Patients With Sickle Cell Disease: A Network Analysis of Pain‐Related Factors in a Single French Sickle Cell Centre

  2025cites this paper
• Associations Between Pain Scores and Opioid Doses With Emergency Department Disposition and Return Visit Rates in Children With Sickle Cell Disease

  2025cites this paper
• Role of CD34 Count as a Prognostic Marker for Vascular Complications in Sickle Cell Disease

  2025cites this paper
• Treating sickle cell disease in resource-limited sub-Saharan Africa: recent strategies and recommendations in addressing the gaps for the provision of evidence-based management

  2025cites this paper
• Evaluation of Potassium, Calcium and Sodium in Sickle Cell Subjects

  2025cites this paper
• C-reactive protein and the menstrual cycle in females with sickle cell disease

  2025cites this paper
• Moderators of digital cognitive-behavioral therapy for youth with sickle cell disease pain: secondary analysis of a randomized controlled trial

  2025cites this paper
• Physical activity, vaso‐occlusive crises and pain in patients with sickle cell anaemia in Senegal

  2025cites this paper
• Prospective cohort study of eDiary acute pain assessments in sickle cell disease during third trimester and postpartum

  2025cites this paper
• Risk factors for immediate postpartum sickle cell disease‐specific maternal morbidity

  2025cites this paper
• Impact of Individualized Versus Weight-Based Pain Protocols on Patient Satisfaction for Patients With Sickle Cell Disease Experiencing a Vaso-Occlusive Episode.

  2025cites this paper
• The Interaction of Pain Catastrophizing and Chronic Pain Acceptance in Sickle Cell.

  2025cites this paper
• Redefining Ten; Reducing the Invisible Pain of Sickle Cell Disease

  2025cites this paper
• Hemoglobin Sickle-Beta-Thalassemia With an Acute Crisis

  2025cites this paper
• Inflammatory Cytokines in Association With High Fetal Hemoglobin Level Reduce the Episodes of Vaso-Occlusive Crisis in Sickle Cell Patients

  2025cites this paper
• New kid on the block: hemorphins in sickle cell disease.

  2025cites this paper
• Emerging pathways in thromboinflammation of sickle cell disease: novel findings in disease pathogenesis

  2025cites this paper
• Hemorphins, atypical endogenous opiate peptides, in sickle cell disease and their association with pain.

  2025cites this paper
• Emergency care for children with sickle cell disease: a focus on pain and fever

  2025cites this paper
• Exploring Perceived Barriers and Facilitators for Implementing Acute Pain Clinical Trials: A Mixed-Methods Analysis of Ketamine Infusions for Sickle Cell Pain

  2025cites this paper
• Arginine Therapy for Pain in Sickle Cell Disease: A Phase‐2 Randomized, Placebo‐Controlled Trial

  2025cites this paper
• Factors influencing willingness to utilize the emergency department when experiencing sickle cell disease pain crises.

  2025cites this paper
• Serum magnesium levels of children living with sickle cell anaemia at the Lagos University Teaching Hospital: a comparative cross-sectional study

  2025cites this paper
• Opioid Control for Patients With Sickle Cell Anemia in Emergency Departments in the Western Region of Saudi Arabia

  2024cites this paper
• Targeted therapeutic management based on phytoconstituents for sickle cell anemia focusing on molecular mechanisms: Current trends and future perspectives.

  2024cites this paper
• Acute Pancreatitis in Individuals with Sickle Cell Disease: A Systematic Review

  2024cites this paper
• Pain specialists in the management of sickle cell disease: a call to action.

  2024cites this paper
• End Organ Affection in Sickle Cell Disease

  2024cites this paper
• Unmet Need: Mechanistic and Translational Studies of Sickle Cell Disease Pain as a Whole Person Health Challenge.

  2024cites this paper
• Opioids used to manage acute pain crisis in adults with sickle cell disease in emergency department: Systematic review

  2024cites this paper
• Roles of Pharmacists in the Management of Sickle Cell Disease in Adults: A Narrative Review

  2024influential citation
• Opioid Prescribing and Outcomes in Patients With Sickle Cell Disease Post-2016 CDC Guideline.

  2024cites this paper
• Digital cognitive behavioral therapy vs education for pain in adults with sickle cell disease

  2024cites this paper
• Les complications de la drépanocytose, de l’enfant à l’adulte

  2024cites this paper
• Management of Acute Complications of Sickle Cell Disease.

  2024cites this paper
• Left ventricular global longitudinal strain and acute myocardial injury in patients with sickle cell disease admitted to the intensive care unit for vaso‐occlusive crisis

  2024cites this paper
• Health-related quality of life of children and adolescents with sickle cell disease: An evolutionary concept analysis.

  2024cites this paper
• Impact of hydroxyurea on follicle density in patients with sickle cell disease

  2024cites this paper
• The Inequality of Pain Control in Patients With Pain From Sickle Cell Disease: A Case Report.

  2024cites this paper
• Web-Based Educational Resources for Patients with Sickle Cell Disease: Availability and Reliability

  2024cites this paper
• Orthognathic surgery in patient with Sickle cell disease: A Case report and review of literature

  2024cites this paper
• Pain-Related Injustice Appraisals, Sickle Cell Stigma, and Racialized Discrimination in the Youth with Sickle Cell Disease: A Preliminary Investigation

  2024cites this paper
• Establishment of a Comprehensive Platform for Sustained Delivery of Yoga Therapy for Sickle Cell Anemia in Rural and Remote Tribal Pocket in India

  2024cites this paper
• Safety and efficacy of ketamine use in patients with vaso‐occlusive crisis: A systematic review and meta‐analysis

  2024cites this paper
• Longitudinal outcomes of chronically transfused adults with sickle cell disease and a history of childhood stroke

  2024cites this paper
• Osteopathic Manipulative Treatment: A Safe and Feasible Adjunct in Sickle Cell Disease Pain Management

  2024cites this paper
• The use of abstract animations and a graphical body image for assessing pain outcomes among adults with sickle cell disease

  2024cites this paper
• Sickle cell disease iPSC-derived sensory neurons exhibit increased excitability and sensitization to patient plasma.

  2024cites this paper
• Sickle Cell Disease in Brazil: Current Management

  2024cites this paper
• Current and Future Therapeutics for Treating Patients with Sickle Cell Disease

  2024cites this paper
• Splenic Sequestration Crisis in Sickle Cell Anemia: A Case Report

  2024cites this paper
• Single nucleotide polymorphisms and sickle cell disease-related pain: a systematic review

  2023cites this paper
• Rate of Complicated and Uncomplicated VOC episodes

  2023cites this paper
• Chronic Pain Management in Sickle Cell Disease: A Systematic Scoping Review of Controlled Trials.

  2023cites this paper
• Confronting racial inequity in health and education: Supporting students with sickle cell disease

  2023cites this paper
• Use of consumer wearables to monitor and predict pain in patients with sickle cell disease

  2023cites this paper
• Pain Control for Sickle Cell Crisis, a Novel Approach? A Retrospective Study

  2023cites this paper
• Regional anesthesia and sickle cell crisis in pediatric patients: An educational‐focused review

  2023cites this paper
• Psychosocial challenges of persons with sickle cell anemia: A narrative review

  2023cites this paper
• Urgenze nell’anemia falciforme dell’adulto

  2023cites this paper
• Red Blood Cells as Therapeutic Target to Treat Sickle Cell Disease

  2023influential citation
• The Efficacy of Carbon Dioxide Paste in Alleviating Pain in Patients After Neck Dissection: Protocol for a Double-Blinded, Randomized Controlled Trial

  2023cites this paper
• Urgences dans la drépanocytose de l’adulte

  2023cites this paper
• Inflammation and autoimmunity are interrelated in patients with sickle cell disease at a steady-state condition: implications for vaso-occlusive crisis, pain, and sensory sensitivity

  2023cites this paper
• Impact of Sickle Cell Disease on Academic Performance: A Cross Sectional Study

  2023cites this paper
• Return visit rates after an emergency department discharge for children with sickle cell pain episodes

  2023cites this paper
• Descending facilitation of nociceptive transmission from the rostral ventromedial medulla contributes to hyperalgesia in mice with sickle cell disease.

  2023cites this paper
• Assessing the occurrence and severity of pre‐ and postendodontic pain in anemic and healthy female patients

  2023cites this paper
• A Challenging Case of Severe Sickle Cell Crisis With Multiorgan Involvement: A Case Report

  2023cites this paper
• Massage therapy for children, adolescents, and young adults: Clinical delivery and effectiveness in hematology and oncology

  2023cites this paper
• Feasibility and Acceptability of Online Recruitment and an Online Brief Mindfulness Intervention Among Patients With Sickle Cell Disease

  2023cites this paper
• Ketamine use for management of vaso‐occlusive pain in pediatric sickle cell disease

  2023cites this paper
• Improving the Emergency Department Management of Sickle Cell Vaso-Occlusive Pain Crisis: The Role and Options of Sublingual and Intranasally Administered Analgesia

  2023cites this paper
• The relationship between pain and sleep in pediatric sickle cell disease

  2023cites this paper
• Sickle cell disease patient plasma sensitizes iPSC-derived sensory neurons from sickle cell disease patients

  2023cites this paper
• Non-pharmacological pain interventions for sickle cell crisis in pediatrics: A scoping review.

  2023cites this paper
• A systematic review to assess the burden of ischemic priapism in patients with sickle cell disease

  2023cites this paper
• Exploring the molecular pathways and therapeutic implications of angiogenesis in neuropathic pain.

  2023cites this paper
• A model of painful vaso-occlusive crisis in mice with sickle cell disease.

  2022cites this paper
• NETs in sickle cell disease, quo vadis?

  2022cites this paper
• Evaluate the severity of bone impairment in different types of sickle cell anemia in Basrah province- Iraq

  2022cites this paper
• Sickle cell disease: A global health concern; pathophysiology, epidemiology and advances in point of care diagnostics

  2022cites this paper
• Exploratory clinical trial to evaluate the efficacy and safety of carbon dioxide paste in healthy people

  2022cites this paper
• Recent advances in “sickle and niche” research - Tribute to Dr. Paul S Frenette -

  2022influential citation
• Sickle Cell Disease, a Review

  2022cites this paper
• Role of Serum Ferritin in Predicting Outcomes of COVID-19 Infection Among Sickle Cell Disease Patients: A Systematic Review and Meta-Analysis

  2022cites this paper
• Evaluation of the Response to Pulpal Sensibility Tests (Cold, EPT) in Anemic and Healthy Women

  2022influential citation
• Management of Salter–Harris Type 1 Fracture Complicated with Osteomyelitis in a Sickle Cell Disease Patient: A Case Report and Review of Literature

  2022cites this paper
• Sickle Cell Disease: A Review.

  2022cites this paper
• Bioimpedance single cell sensing of low and high density sickle erythrocytes using microfluidics

  2022cites this paper
• Lidocaine and Ketamine Infusions as Adjunctive Pain Management Therapy: A Retrospective Analysis of Clinical Outcomes in Hospitalized Patients Admitted for Pain Related to Sickle Cell Disease

  2022cites this paper
• Prevalence of neuropathic pain in adolescents with sickle cell disease: A single‐center experience

  2022cites this paper
• Moving Toward a Multimodal Analgesic Regimen for Acute Sickle Cell Pain with Non-Opioid Analgesic Adjuncts: A Narrative Review

  2022cites this paper
• Regional anesthesia for sickle cell disease vaso‐occlusive crisis: A single‐center case series

  2022cites this paper
• Inhibition of DAGLβ as a therapeutic target for pain in sickle cell disease

  2022cites this paper
• Opioid Use in Patients With Sickle Cell Disease During a Vaso-Occlusive Crisis: A Systematic Review

  2022influential citation